1 – 10 of 10
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Difficult-to-treat HIV in Sweden : a cross-sectional study
(
- Contribution to journal › Article
- 2023
-
Mark
Impact of pre-antiretroviral treatment HIV-RNA on time to successful virological suppression and subsequent virological failure - two nationwide, population-based cohort studies
(
- Contribution to journal › Article
- 2021
-
Mark
Longitudinal Follow Up of Immune Responses to SARS-CoV-2 in Health Care Workers in Sweden With Several Different Commercial IgG-Assays, Measurement of Neutralizing Antibodies and CD4
+ T-Cell Responses.
(
- Contribution to journal › Article
- 2020
-
Mark
Antiretroviral treatment for HIV infection : Swedish recommendations 2019
(
- Contribution to journal › Scientific review
-
Mark
Serum-IgG responses to SARS-CoV-2 after mild and severe COVID-19 infection and analysis of IgG non-responders
(
- Contribution to journal › Article
- 2018
-
Mark
Effect of dolutegravir in combination with Nucleoside Reverse Transcriptase Inhibitors (NRTIs) on people living with HIV who have pre-existing NRTI mutations
(
- Contribution to journal › Article
- 2017
-
Mark
Virological failure and all-cause mortality in HIV-positive adults with low-level viremia during antiretroviral treatment
(
- Contribution to journal › Article
- 2016
-
Mark
Viral blips during suppressive antiretroviral treatment are associated with high baseline HIV-1 RNA levels
(
- Contribution to journal › Article
- 2014
-
Mark
Prophylaxis and treatment of HIV-1 infection in pregnancy: Swedish recommendations 2013
(
- Contribution to journal › Scientific review
- 2011
-
Mark
Prophylaxis and treatment of HIV-1 infection in pregnancy: Swedish Recommendations 2010
(
- Contribution to journal › Scientific review